Literature DB >> 657532

Dosage of hemoglobin A1c by isoelectrofocusing.

R Schoos, S Schoos-Barbette, C Lambotte.   

Abstract

A new Hb A1c routine dosage method is proposed, using thin-layer isoelectrofocusing. The mean level in normal adults is 4.66% (sigma = 1.05). In diabetic (treated) patients, the distribution of Hb A1c levels is a non-Gaussian one, with extreme values of 3 to 13% and a maximum frequency peak at 5.5%.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 657532     DOI： 10.1016/0009-8981(78)90458-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  5 in total

1.  Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.

Authors:  A J Scheen; J Gillet; J Rosenthaler; J Guiot; P Henrivaux; B Jandrain; P J Lefèbvre
Journal:  Diabetologia       Date:  1989-11       Impact factor: 10.122

2.  Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin.

Authors:  A S Luyckx; J C Daubresse; C Jaminet; A Scheen; P J Lefebvre
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun

3.  Circadian profiles of blood glucose and plasma free insulin during treatment with semisynthetic and biosynthetic human insulin, and comparison with conventional monocomponent preparations.

Authors:  M Castillo; A Nemery; E Verdin; P J Lefebvre; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.

Authors:  J Gérard; A S Luyckx; P J Lefebvre
Journal:  Diabetologia       Date:  1981-11       Impact factor: 10.122

5.  Characterization of immunoregulatory T lymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies.

Authors:  F Mascart-Lemone; G Delespesse; H Dorchy; B Lemiere; G Servais
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.